Ketan Gujarathi
About Ketan Gujarathi
Ketan Gujarathi is the Executive Director of Cell Therapy (CAR-T) Operations at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in pharmaceutical manufacturing and strategic business operations.
Company
Ketan Gujarathi currently works at Bristol Myers Squibb as the Executive Director, Cell Therapy (CAR-T) Operations. The firm, located in Summit, New Jersey, United States, is renowned for its contributions to the biopharmaceutical industry, focusing on discovering, developing, and delivering innovative medicines to treat various serious illnesses.
Title
Ketan Gujarathi holds the position of Executive Director, Cell Therapy (CAR-T) Operations at Bristol Myers Squibb. In this role, he is responsible for overseeing the operations related to cell therapy, a critical area in the innovation of treatments for life-threatening illnesses such as cancer.
Education and Expertise
Ketan Gujarathi has attained advanced educational qualifications. He completed an MBA from Rutgers Business School (2017-2020), studied Business at Harvard Business School Online, and earned a degree in Biomedical Engineering from the New Jersey Institute of Technology. Additionally, he pursued the General Management Program at CEDEP - Executive Development – Fontainebleau (2023-2024). His education provides a strong foundation in both technical and managerial expertise, suitable for leading complex operations in the biopharmaceutical field.
Career Background
Ketan Gujarathi has an extensive career in the pharmaceutical and biopharmaceutical industries. His previous roles at Bristol Myers Squibb include General Manager, Biologics Drug Substance Operations in Syracuse, NY; Senior Director, Strategy & Business Operations; Director, Strategy & Business Operations, Global Manufacturing Operations; and Associate Director roles in Internal Manufacturing Business Operations and Biologics Network Business Operations. Before joining Bristol Myers Squibb, he worked at Catalent Pharma Solutions in various quality assurance and engineering roles, and at Temptime Corporation as Manager, Quality Engineering.
Achievements
Ketan Gujarathi led the value stream for a life-saving commercial cell therapy medicine at Bristol Myers Squibb's largest cell therapy manufacturing facility. He successfully managed a complex facility divestiture as a site head and implemented global manufacturing governance and continuous improvement deployment. His strategic recommendations have had impacts exceeding $1 billion, and he routinely provided updates to C-Suite leaders. He emphasizes talent engagement and development in his leadership approach, ensuring high-performance teams in the pharmaceutical manufacturing sector.